David Lapointe

David Lapointe

President and CEO, Optina An entrepreneur by nature with a keen eye for identifying opportunities. Results-oriented with a mission to benefit the advancement of the healthcare industry with a ROI for stakeholders.

LinkedIn: https://www.linkedin.com/in/david-lapointe-6068b31/
Montreal, Canada
Member since August 30, 2018
President and CEO, Optina Quote_down
  • About
Investor interests
Locations of interest
Credentials None
1997 Université de Sherbrooke , MS , Biotechnology
1999 Université de Sherbrooke , MS , Medical Imaging

I am a(n):


Companies I've founded or co-founded:
Advanced Molecular Imaging, Facten, Sirius Medical Wilderness
Companies I work or worked for:
GE Healthcare, Gamma Medica Ideas
Achievements (products built, personal awards won):

Product built:
PET scanners for research
Retinal camera

Awards :
CDL finalist
Western Investment Forum Award

If you're an entrepreneur or corporate innovator, why?

Serendipitously fell into it...

My favorite startups:


What's most frustrating and rewarding about entrepreneurship/innovation?

Most Frustrating - not moving fast enough. Startups often evolve at a different past then partners (Academia, gov, commercial partners)...

Most Rewarding: achieving something, building moving forward.

What's the No. 1 mistake entrepreneurs/innovators make?

Lack of vision alignment between stakeholders.

What are the top three lessons you've learned as an entrepreneur?

Learned to take a beating and listen sometimes
Focus on the right objectives/problems
Surround yourself with great people

Full bio

David Lapointe, M.Sc Founder, President and CEO

David held the position of General manager at GE Healthcare were he managed the global operation for Molecular Imaging and Research. During his tenure at GE Healthcare, David increased distribution by adding new global markets.   David founded Advanced Molecular Imaging (AMI) in Sherbrooke, Canada to bring molecular imaging technologies to the global pharma and research market. AMI developed the world’s first fully digital PET imaging system. In addition to successfully securing all funding for AMI, David completed a successful sale of AMI Mr. Lapointe’s early career included sales and marketing positions in the pharma industry.